Mon May 20 22:46:50 SGT 2013  
SHIM CLINIC
HIV STD TESTING TREATMENT™
168 Bedok South Avenue 3 #01-473
Singapore 460168
Tel: (+65) 6100 7446
Fax: (+65) 6449 7446
24hr Answering Tel: (+65) 6333 5550
Web: www.ShimClinic.com
Opening Hours
Monday to Friday: 9 am to 3 pm, 7 pm to 11 pm
Saturday & Sunday: 7 pm to 11 pm
Public Holidays: Closed
Last registration: half hour before closing time.
Walk-in clinic. Appointments not required.
Bring NRIC, Work Pass or Passport for registration.

Within 3 days after unprotected sex, stop HIV infection with Post-Exposure Prophylaxis treatment 10 days after unprotected sex, detect HIV infection with the DNA test 28 days after unprotected sex, accurately detect HIV infection with the 20 minute rapid test
Full & comprehensive sexually transmitted disease testing
Males: do not urinate for at least 4 hours before arriving
Females: testing is more accurate when you are not menstruating

HPV Vaccine | Shim Clinic, Singapore | HIV STD TESTING TREATMENT™

Summary

HPV Vaccine | Shim Clinic, Singapore | HIV STD TESTING TREATMENT™: Human papillomavirus (HPV) vaccine jab/shot/injection schedule, to vaccinate against the HPV, to immunise against cervical/penile/anal/mouth/throat cancer and genital warts clinic, Singapore. Private and confidential service. Definitions, references, and latest news.

Description

Table of Contents

Since 2006, two HPV vaccines have been licensed; one vaccine targets four and the other two HPV genotypes. Both vaccines are designed to protect against about 70% of cervical cancer cases worldwide (the 4-valent vaccine also protects against genital warts). The vaccines are intended for use primarily in adolescent girls aged 10–14 years. The complete series of quadrivalent vaccine is administered at day 0; 2 months; and 6 months. The bivalent vaccine is administered at day 0; 1 month; and 6 months. Repeating previous doses is not necessary if the 3-dose programme has been interrupted. Booster doses are currently not recommended. Over the next few years, HPV vaccination will be introduced into the immunization schedules of several countries.

HPV vaccine (previously known as cervical cancer vaccine) types:

  • Gardasil® [HPV (Human Papillomavirus) Quadrivalent (Types 6, 11, 16, and 18) Vaccine, Recombinant]
  • Cervarix® [HPV (Human Papillomavirus) Bivalent (Types 16 and 18) Vaccine, Recombinant]
  • V503 [HPV (Human Papillomavirus) Nonavalent (Types 6, 11, 16, 18, 31, 33, 45, 52, and 58) Vaccine, Recombinant]
References Gardasil® [HPV (Human Papillomavirus) Quadrivalent (Types 6, 11, 16, and 18) Vaccine, Recombinant] References Cervarix® [HPV (Human Papillomavirus) Bivalent (Types 16 and 18) Vaccine, Recombinant] References V503 [HPV (Human Papillomavirus) Nonavalent (Types 6, 11, 16, 18, 31, 33, 45, 52, and 58) Vaccine, Recombinant] - to be released in 2013 STD vaccine / hepatitis vaccine shot/jab/injection to prevent some STDs

Vaccine Against Disease Age D
o
s
e
s
Dose schedule Price
per
dose
(SG$)
Havrix™ 1440 Adult Hepatitis A virus Hepatitis A ≥19y 2 m 0 & 6-12 $90/=
Twinrix® Hepatitis A virus
Hepatitis B virus
Hepatitis A
Hepatitis B
1-15y 2 m 0, 6-12 $120/=
≥16y 3 m 0, 1, 6
4 d 0, 7, 21 & m 12
Inactivated / Fractional / Protein / Subunit / Recombinant
Engerix™-B 20 μg Hepatitis B virus Hepatitis B 11-15y 2 m 0, & 6 $50/=
≥20y 3 m 0, 1, & 6
4 m 0, 1, 2, & 12 or
d 0, 7, 21 & m 12
Gardasil® HPV
types 6, 11, 16, & 18
Genital warts
Cervical cancer
9-26y 3 m 0, 2, & 6 or
m 0, 1, & 4
$195/=
Cervarix® HPV
types 16, & 18
(31, 33, & 45)
10-25y 3 m 0, 1, & 6
m 0, 1, & 5
m 0, 2½, 12
$195/=
V503 HPV
types 6, 11, 16, 18,
31, 33, 45,
52, & 58
3 m 0, 2, & 6 or
m 0, 1, & 4
$???/=

HPV test for men/women.

  • Digene® High-Risk HPV DNA Test
  • Digene® HPV DNA Test
  • Digene® HPV Genotyping PS Test
  • Hybribio®
    • HPV GenoArray Test Kit
    • Detects 15 high-risk HPV types: 16, 18, 31, 33, 35, 39, 45, 51, 52, 53, 56, 58, 59, 66, and 68. And 6 low-risk HPV types: 6, 11, 42, 43, 44, CP8304
    • Able to differentiate which types are positive.
    • May be available in Singapore soon.
  • Cobas® HPV Test
    • Cobas® HPV Test
    • Detects 14 high-risk HPV types: 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66, and 68
    • The test specifically identifies (types) HPV 16 and HPV 18, while concurrently detecting the rest of the high risk types (31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66, and 68)
    • Cost is SG$200/=
  • LINEAR ARRAY® HPV Genotyping Test
    • LINEAR ARRAY® HPV Genotyping Test
    • Identifies 37 high-risk HPV genotypes 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66, 68, 73 (MM9), 82 (MM4) low-risk HPV genotypes 6, 11, 26, 40, 42, 53, 54, 55, 61, 62, 64, 67, 69, 70, 71, 72, 81, 83 (MM7), 84 (MM8), IS39, and CP6108
  • INNO-LiPA HPV Genotyping Extra
    • INNO-LiPA HPV Genotyping Extra
    • Identifies 15 high-risk HPV genotypes (16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 68, 73, 82) 3 probable high-risk HPV genotypes (26, 53, 66) 7 low-risk HPV genotypes (6, 11, 40, 43, 44, 54, 70) and some additional types (69, 71, 74).
  • PapilloCheck®
    • PapilloCheck®
    • Identifies 24 hiv-risk HPV types 16 18 31 33 35 39 45 51 52 53 56 58 59 66 68 70 73 82 and low-risk HPV types 6 11 40 42 43 44

HPV / human papillomavirus. There are nearly 200 known types of HPV. They cause

Major HPV types: References Genital HPV types, cancer risk, vaccine and test coverage

HPV1
6
1
8
3
1
3
3
3
5
3
9
4
5
5
1
5
2
5
6
5
8
5
9
6
8
7
0
7
3
8
2
2
6
5
3
6
6
61
1
4
0
4
2
4
3
4
4
5
4
5
5
6
1
6
2
6
4
6
7
6
9
7
1
7
2
8
1
8
3
8
4
C
P
6
1
0
8
I
S
0
3
9
7
4
RiskHHHHHHHHHHHHHHHHIIILLLLLLLLLLLLLLLLLLLLU
Cervarix++--------------------------------------
Gardasil++-----------------++-------------------
V503++++--+-+-+--------++-------------------
DigeneHR+++++++++++++---------------------------
DigenePS++----+---------------------------------
CobasHPV+++++++++++++-----+---------------------
Digene+++++++++++++------++-+++---------------
HybriBio+++++++++++++----++++-+++---------+-----
PapilloCheck++++++++++++++++-++++++++---------------
InnoLiPA++++++++++++++++++++++-+++-----++------+
LinearArray+++++++++++++++++++++++--++++++++++++++-

Legend: 71 (CP 8061), 81 (CP 8304), 82/MM4, 82/IS039, 83 (MM7), 84 (MM8)

References

Cervical cancer Genital warts: penile warts / vaginal warts / anal warts / anogenital warts / venereal warts / condyloma / condylomata acuminata / "cauliflower" sex disease.

References

Warts - on male sex organ Genital warts appear within 3 months after sexual contact with an infected person.

Genital warts:

  • are usually soft, pink cauliflower-like growths or flesh-coloured bumps on the sex organs
  • may also be hard and smooth
  • occur alone or in groups
  • tend to recur after treatment
  • increase the risk of cervical cancer in women.


Warts - on female sex organ An infected woman may infect her newborn during childbirth.

A person with genital warts can infect others through sexual contact.



Genital warts treatment / HPV treatment

Sexual risk (of HIV/STD/pregnancy), and what you can do before and after exposure.

Timeline Event / Available resources
HIV STD Pregnancy
Before exposure
Abstain from sex, Be faithful, or Condom use
Circumcision (males only)
Contraception
(females only)
HIV PrEP (pre-exposure prophylaxis) STD vaccine:
- Hepatitis vaccine
- HPV vaccine
STD / HIV exposure
Unsafe sex / unprotected sex:
No condom / Condom broke / Condom slip
0-72 hours HIV prevention
HIV PEP (post-exposure prophylaxis) treatment
- Stop HIV infection after exposure.
STD testing
If STD symptoms appear, then do STD treatment.
- Males: Do not urinate for at least 4 hours before arriving.
- Females: testing is more accurate when you are not menstruating.
Emergency contraception
(females only)
2 weeks HIV DNA PCR test
1 month 20 minute Alere™ Determine™ Combo HIV rapid test:
- Fingerprick blood sampling.
- Cost is SG$180/=
3 months 20 minute OraQuick® HIV rapid test:
- Oral saliva or
- Fingerprick blood sampling.
- Cost is SG$60/=
Full & comprehensive STD testing
- Males: Do not urinate for at least 4 hours before arriving.
- Females: testing is more accurate when you are not menstruating.

Note: If the clinic attendance is only for the HIV rapid test, then consultation fees are not added.

References


Latest News

Australian boys become first male guinea pigs in global Gardasil genocide
Wed, 27 Feb 2013 06:00:00 +0100 | NaturalNews.com
Nearly one million teenage boys living in Australia are set to be vaccinated with the human papillomavirus (HPV) vaccine Gardasil in the coming months and years, according to new reports. The first country in the world to give an official green light to the vaccine's... (Source: NaturalNews.com)

HMP recommends approval of extension to Cervarix® human papillomavirus vaccine therapeutic indication
Mon, 25 Feb 2013 05:00:00 +0100 | NeLM - News
Source: European Medicines Agency

[Correspondence] Cross protection against HPV might prevent type replacement
Tue, 19 Feb 2013 19:17:44 +0100 | The Lancet Infectious Diseases
Duration of efficacy of the two prophylactic human papillomavirus (HPV) vaccines Cervarix and Gardasil is the most important question for population control of HPV infection, and if the duration exceeds 15 years, the control of cervical cancer. The phase 2 randomised controlled trials were designed to show 5 year efficacy for Gardasil, and 9·4 year efficacy for Cervarix; both phase 3 trials were ended before 4 years. HPV16 and HPV18, the most aggressive oncogenic HPV types, are the main vaccine targets, and have 17% and 11% cumulative incidences of cervical intraepithelial neoplasia grade 3 or greater (CIN3+) over a 10 year period, respectively. (Source: The Lancet Infectious Diseases)

Human Papillomavirus Types Distribution in Eastern Sicilian Females with cervical lesions. A Correlation with Colposcopic and Histological Findings.
Tue, 19 Feb 2013 05:00:00 +0100 | Pathology Oncology Research
Authors: Le Donne M, Giuffrè G, Caruso C, Nicotina PA, Alibrandi A, Scalisi R, Simone A, Chiofalo B, Triolo O

Can clinical tests help monitor human papillomavirus vaccine impact?
Tue, 19 Feb 2013 05:00:00 +0100 | International Journal of Cancer
ABSTRACT

Herd immunity effect of the HPV vaccination program in Australia under different assumptions regarding natural immunity against re-infection.
Tue, 19 Feb 2013 05:00:00 +0100 | Vaccine
Authors: Korostil IA, Peters GW, Law MG, Regan DG

Attitudes Toward HPV Vaccination Among Low-Income and Minority Parents of Sons: A Qualitative Analysis
Fri, 15 Feb 2013 05:00:00 +0100 | Clinical Pediatrics
Conclusions. Low-income and minority parents/guardians were generally receptive toward vaccinating their sons against HPV; racial/ethnic differences emerged regarding school-entry mandates. (Source: Clinical Pediatrics)

Australia launches national scheme to vaccinate boys against HPV
Thu, 14 Feb 2013 05:00:00 +0100 | NeLM - News
Source: BMJ

Validation of Decisional Balance and Self-Efficacy Measures for HPV Vaccination in College Women.
Tue, 12 Feb 2013 05:00:00 +0100 | American Journal of Health Promotion : AJHP
Conclusion. Findings support the internal and external validity of these measures and their use in Transtheoretical Model-tailored interventions. Stage-construct relationships suggest that reducing the Cons of vaccination may be more important for HPV than for behaviors with a true Maintenance stage.

Applying a gender lens on human papillomavirus infection: cervical cancer screening, HPV DNA testing, and HPV vaccination
Fri, 08 Feb 2013 05:00:00 +0100 | International Journal for Equity in Health
Conclusions:


ABOUT TRUST ONLINE